# REPLIGEN CORP (RGEN) FY2026 Q2 Balance Sheet

- Company: REPLIGEN CORP (RGEN)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0001193125-26-323773
- Page: https://plicit.ai/financials/rgen/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/rgen-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,950,180,000 US dollars
- **Current assets**: 1,200,554,000 US dollars
- **Non-current assets**: 1,749,626,000 US dollars
- **Liabilities**: 838,148,000 US dollars
- **Current liabilities**: 132,656,000 US dollars
- **Non-current liabilities**: 705,492,000 US dollars
- **Equity**: 2,112,032,000 US dollars
- **Cash and cash equivalents**: 606,783,000 US dollars
- **Marketable securities**: 203,666,000 US dollars
- **Inventories, net**: 186,604,000 US dollars
- **Accounts receivable, net of allowances of $3,099 and $2,767 at June 30, 2026 and December 31, 2025, respectively**: 157,710,000 US dollars
- **Prepaid expenses and other current assets**: 45,791,000 US dollars
- **Goodwill**: 1,104,183,000 US dollars
- **Intangible assets, net**: 357,622,000 US dollars
- **Property, plant and equipment, net**: 167,513,000 US dollars
- **Operating lease right of use assets**: 115,559,000 US dollars
- **Other noncurrent assets**: 4,049,000 US dollars
- **Deferred tax assets**: 700,000 US dollars
- **Accrued liabilities**: 77,080,000 US dollars
- **Accounts payable**: 33,233,000 US dollars
- **Operating lease liabilities**: 19,318,000 US dollars
- **Contingent consideration**: 3,025,000 US dollars
- **Convertible Senior Notes due 2028, net**: 551,046,000 US dollars
- **Noncurrent operating lease liabilities**: 120,578,000 US dollars
- **Other noncurrent liabilities**: 17,090,000 US dollars
- **Deferred tax liabilities**: 16,778,000 US dollars
- **Noncurrent contingent consideration**: 0 US dollars
- **Additional paid-in capital**: 1,661,665,000 US dollars
- **Retained earnings**: 469,589,000 US dollars
- **Common stock, $0.01 par value; 80,000,000 shares authorized; 56,427,067 shares at June 30, 2026 and 56,325,429 shares at December 31, 2025 issued and outstanding**: 564,000 US dollars
- **Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued or outstanding**: 0 US dollars
- **Accumulated other comprehensive loss**: negative 19,786,000 US dollars
- **Gross equity (calculated)**: 2,131,818,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.